Purchase Order 75N93020P00594

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $10,736.64 on August 11, 2020. The order covers ten HISPEED Plasmid Maxi Kits at $252.00 each, priced on a firm fixed-price basis. Work is performed in Germantown, Maryland, with an ultimate completion date of September 6, 2020. No small business set-aside applies.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $12,515.20 on August 25, 2020 for a Tissue Lyser II instrument including adapters for 96-well and 24-well plates, with additional funding for a handling charge. Performance is located in Germantown, Maryland. The order carries firm fixed price terms with an ultimate completion date of September 24, 2020.</p>

The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $4,094.11 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. This award does not have a set-aside designation. The award supports Qiagen's provision of products and services to NIAID, such as DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and bioinformatics...

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $18,726 firm fixed-price purchase order to Qiagen, LLC for an annual service agreement covering three Qiagility HEPA/UV robotic workstations under the FY26 UDO Initiative. The award, issued on May 12, 2024, with performance through May 11, 2025, represents a non-competitive procurement without set-aside designation. The work will be performed at NIAID's facility in Bethesda, Maryland. Qiagen, a Germantown,...

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $13,936.20 in QIAcube-compatible QIAseq sequencing kits on September 13, 2021, with ultimate completion on July 7, 2022. The order was issued to de-obligate unexpiring fiscal year 2021 funds in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 period-of-availability close. Performance takes place in Germantown, Maryland. The purchase order carries firm fixed price pricing...

The National Institute of Allergy and Infectious Diseases awarded a $17,013.02 firm fixed-price purchase order to Qiagen, LLC for the QIASEQ FastSelect 5S/16S/23S Kit (384). This contract, awarded on September 16, 2021, with an ultimate completion date of September 24, 2021, represents a straightforward procurement of specialized molecular biology reagents used for ribosomal RNA depletion and sample preparation in next-generation sequencing applications. The award includes no set-aside...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for a PCR system on March 19, 2020, with a ceiling value of $16,503.50 and ultimate completion date of April 16, 2020. Performance took place in Germantown, Maryland. The order was priced on a firm fixed-price basis with no set-aside applied.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order valued at $13,166 to Qiagen, LLC of Germantown, Maryland. The one-year contract provides full agreement service for two QIACUBE HT/QIAXTRACTOR platforms from July 1, 2023 to June 30, 2024. Qiagen, LLC is a subsidiary of Qiagen N.V. and will perform the entirety of the contract within the United States. The award is likely in...

This is a firm fixed-price purchase order awarded to Qiagen, LLC by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract has a ceiling value of $16,101.84 and a period of performance through May 11, 2024. The award does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V. Qiagen provides a range of products and services to support federal...

Qiagen, LLC has been awarded a firm fixed price purchase order totaling $18,780.30 by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for an annual service agreement to provide support for Qiagen's QIAcuity Eight Digital PCR System in Bethesda, Maryland through February 27, 2025. No set-aside designation was used for this award to support the agency's research into allergies and infectious...